Hikma Pharmaceuticals PLC

HKMPY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$455$281$233$544
Dep. & Amort.$197$198$193$145
Deferred Tax$0$0$0-$89
Stock-Based Comp.$27$25$22$29
Change in WC-$135$80-$131-$30
Other Non-Cash$20$24$213$39
Operating Cash Flow$564$608$530$638
Investing Activities
PP&E Inv.-$165-$169-$225-$229
Net Acquisitions-$162-$105-$380-$17
Inv. Purchases-$2-$27-$15-$3
Inv. Sales/Matur.$0$1$0$6
Other Inv. Act.-$52-$33$13$5
Investing Cash Flow-$381-$333-$607-$238
Financing Activities
Debt Repay.$124-$93$456-$83
Stock Issued-$38$0$0$0
Stock Repurch.$0$0-$300$0
Dividends Paid-$175-$137-$125-$120
Other Fin. Act.-$99-$107-$89-$84
Financing Cash Flow-$188-$337-$58-$287
Forex Effect-$12-$3-$21-$10
Net Chg. in Cash-$17-$65-$156$103
Supplemental Information
Beg. Cash$205$270$426$323
End Cash$188$205$270$426
Free Cash Flow$329$404$305$409